Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Webb

Showing results (41-50 of 360) with videos related to

Pageof 36
Sort By:
Drugs|January 1, 1996
The clinical potential of endothelin receptor antagonists in cardiovascular medicineC J Ferro, D J Webb
Lancet (London, England)|September 24, 1994
Enhanced basal nitric oxide production in heart failureD J Webb, J J McMurray
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 1998
A modified human alpha 2-macroglobulin derivative that binds tumor necrosis factor-alpha and interleukin-1 beta with high affinity in vitro and reverses lipopolysaccharide toxicity in vivo in miceD J Webb, S L Gonias
Experimental Cell Research|July 1, 1973
Relation between ionic coupling and morphology of established cells in cultureD F Hülser, D J Webb
Biophysik|January 1, 1973
The use of the tip potential of glass microelectrodes in the determination of low cell membrane potentialsD F Hülser, D J Webb
Lancet (London, England)|January 1, 1999
Clinical pharmacology. Blue-chip technologyD A Flockhart, D J Webb
The American Journal of Physiology|November 1, 1993
Venoconstriction to endothelin-1 in humans: role of calcium and potassium channelsW G Haynes, D J Webb
Journal of Cardiovascular Pharmacology|January 1, 1986
Vascular angiotensin conversion in humansD J Webb, J G Collier
FEBS Letters|June 30, 1997
Chemical modification of alpha2-macroglobulin to generate derivatives that bind transforming growth factor-beta with increased affinityD J Webb, S L Gonias
The American Journal of Cardiology|April 24, 1987
Influence of ramipril diacid on the peripheral vascular effects of angiotensin ID J Webb, J G Collier
Pageof 36

Showing results (41-50 of 360) with videos related to

Sort By:
Pageof 36
Drugs|January 1, 1996
The clinical potential of endothelin receptor antagonists in cardiovascular medicineC J Ferro, D J Webb
Lancet (London, England)|September 24, 1994
Enhanced basal nitric oxide production in heart failureD J Webb, J J McMurray
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 26, 1998
A modified human alpha 2-macroglobulin derivative that binds tumor necrosis factor-alpha and interleukin-1 beta with high affinity in vitro and reverses lipopolysaccharide toxicity in vivo in miceD J Webb, S L Gonias
Experimental Cell Research|July 1, 1973
Relation between ionic coupling and morphology of established cells in cultureD F Hülser, D J Webb
Biophysik|January 1, 1973
The use of the tip potential of glass microelectrodes in the determination of low cell membrane potentialsD F Hülser, D J Webb
Lancet (London, England)|January 1, 1999
Clinical pharmacology. Blue-chip technologyD A Flockhart, D J Webb
The American Journal of Physiology|November 1, 1993
Venoconstriction to endothelin-1 in humans: role of calcium and potassium channelsW G Haynes, D J Webb
Journal of Cardiovascular Pharmacology|January 1, 1986
Vascular angiotensin conversion in humansD J Webb, J G Collier
FEBS Letters|June 30, 1997
Chemical modification of alpha2-macroglobulin to generate derivatives that bind transforming growth factor-beta with increased affinityD J Webb, S L Gonias
The American Journal of Cardiology|April 24, 1987
Influence of ramipril diacid on the peripheral vascular effects of angiotensin ID J Webb, J G Collier
Pageof 36